Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
05/14/2008 | CN100387291C Medicine for treating pulmonary tuberculosis |
05/14/2008 | CN100387290C Ointment for curing fracture and preparation method |
05/14/2008 | CN100387289C Canine oil ointment for curing burn and stopping pain |
05/14/2008 | CN100387282C Use of composition in preparing medicine for preventing and treating cutitis |
05/14/2008 | CN100387281C Use of composition in preparing medicine for preventing and treating itching skin |
05/14/2008 | CN100387280C Phlegm transforming Chinese medicinal formulation for children and its preparation method |
05/14/2008 | CN100387279C Chinese medicine preparation for treating malignant tumor |
05/14/2008 | CN100387278C Chinese patent medicine for treating cow sterility |
05/14/2008 | CN100387277C Preparation method of notoginseng-containing tablet for treating traumatic injury |
05/14/2008 | CN100387276C Bone-activating ointment |
05/14/2008 | CN100387275C Oral Chinese medicine composition for treating malignant tumor |
05/14/2008 | CN100387274C Chinese medicine for treating postpartum continuous lochia, incomplete miscarriage, menstrual pain |
05/14/2008 | CN100387270C Traditional Chinese medicine formulation for treating and preventing diabetes and its angiopathy |
05/14/2008 | CN100387260C Eye medicine for treating senile cataract and its pH value regulating method and preparing process thereof |
05/14/2008 | CN100387259C Capsule for treating rheumatic and rheumatoid arthritis and its preparing process |
05/14/2008 | CN100387257C Chinese medicine for treating fractures and processing technology thereof |
05/14/2008 | CN100387256C Medicine for treating gastric, anal and intestinal diseases |
05/14/2008 | CN100387244C Composition for anti osteo porosis |
05/14/2008 | CN100387242C American ginseng and royal jelly soft capsule |
05/14/2008 | CN100387240C An extract of faeces bombycis |
05/14/2008 | CN100387153C Method for preparing blood sugar-decreasing, stomach-benefiting, health-preserving soybean yoghurt with micron holoside, ginseng, solomonseal, chlorophyll, propolis and chromium powder |
05/14/2008 | CN100387144C Method for preparing digestion-promoting spleen-invigorating soybean milk powder with micron chickens gizzard-membrane powder, coix seed powder, white hyacinth bean powder, yam powder and pine pollen |
05/14/2008 | CN100387143C Method for preparing yang-invigorating, fatigue-alleviating soybean milk powder with micron pine pollen, antler powder, deer bone powder, deer sinew powder, bull penis powder and donkey penis powder |
05/14/2008 | CN100387142C Method for preparing yin-nourishing health-preserving soybean milk powder with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian |
05/14/2008 | CN100387141C Method for preparing yin-nourishing health-preserving soybean milk powder with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian |
05/14/2008 | CN100387137C Preparation method of digestive and Yiwei bean milk powder with micro-meter Huaguoshan sugar and golden monkey |
05/14/2008 | CN100387136C Method for preparing milk liquor contg. micron additives for tonifying-Yin and eliminating fatigue |
05/14/2008 | CN100387125C Dog-like sperm super-low temperature freezing preservation antifreeze solution |
05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
05/13/2008 | US7371576 CD56 positive human adult pancreatic endocrine progenitor cells |
05/13/2008 | US7371575 Process for ex vivo formation of mammalian bone and uses thereof |
05/13/2008 | US7371410 Bone graft substitute composition |
05/13/2008 | US7371408 Bone graft substitute composition |
05/13/2008 | US7371407 the oil is used as a carrying agent for anti-microbial formulations; comprises terbinafine and other antibiotics; for topical application to the skin or mucosal membranes of a mammal |
05/13/2008 | US7371400 Multilayer device for tissue engineering |
05/13/2008 | US7371374 Neural transplantation using pluripotent neuroepithelial cells |
05/13/2008 | CA2360833C Reovirus for the treatment of cellular proliferative disorders |
05/13/2008 | CA2252758C Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries |
05/08/2008 | WO2008054293A1 Composition, its use for treating systemic diseases a conditions, and product containing said composition |
05/08/2008 | WO2008054247A1 Method for producing apyrogenic immunomodulator |
05/08/2008 | WO2008054238A1 Biologically active preparation (variants) and a method for the production thereof (variants) |
05/08/2008 | WO2008054184A1 Composition for treatment of cervix cancer |
05/08/2008 | WO2008053892A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
05/08/2008 | WO2008053728A1 Agent for promoting healing of living body |
05/08/2008 | WO2008053588A1 Cytokine production regulator gene and use thereof |
05/08/2008 | WO2008053444A2 Treating a respiratory condition with bifidobacterium |
05/08/2008 | WO2008052468A1 New lactobacillus rhamnosus strain, its pharmaceutical composition and the uses thereof, and the method for preparation |
05/08/2008 | WO2008052326A1 Composition for the treatment of skin conditions |
05/08/2008 | WO2008052302A1 System and process for producing a low-suspended solids solution and uses therefore |
05/08/2008 | WO2008030964A3 Use of noncalcium zeolites with added calcium salt in hemostatic devices and products |
05/08/2008 | WO2007143957A3 'transfer factor' medicament - ways of manufacturing and use |
05/08/2008 | WO2007085970A3 Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders |
05/08/2008 | WO2007044062A8 Bile preparations for gastrointestinal disorders |
05/08/2008 | US20080108134 Extracellular matrix tisuse comprised of cultured fibroblast for use in grafting to patient with tissue or organ defect; safety testing for pharmaceutical, cosmetic and chemical products |
05/08/2008 | US20080108046 Method of sorting cells |
05/08/2008 | US20080108045 Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin |
05/08/2008 | US20080107763 Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle |
05/08/2008 | US20080107762 Reducing a cholinergic influenced secretion; treating smooth muscle disorders such as spasms |
05/08/2008 | US20080107753 Compositions to alleviate menopausal symptoms |
05/08/2008 | US20080107752 Detoxified venom and constituent neurotoxins; alpha-bungarotoxin, kappa-bungarotoxin, alpha-cobratoxin, alpha-cobrotoxin, alpha-conotoxins, alpha-dendrotoxin, erabutoxin; protect from viral, bacterial, parasitic infections; administer orally, subcutaneously, intramuscularly, intravenously |
05/08/2008 | US20080107751 Wax bath is solid at room temperature; an anti-microbial agent inhibit growth of micro-organisms in the wax in the liquid state; fragrance; mineral oil, animal, vegetable oils; jojoba oil, emu oil, aloe vera oil; paraffin wax; hand, foot, elbow or other appendage is dipped or immersed in molten wax |
05/08/2008 | US20080107750 Graft materials containing ecm components, and methods for their manufacture |
05/08/2008 | US20080107714 Use of a vector comprising a nucleic acid encoding an anti-angiogenic factor for the treatment of corneal neovascularization |
05/08/2008 | US20080107699 Method of using topical probiotics for the inhibition of surface contamination by a pathogenic microorganism and composition therefor |
05/08/2008 | US20080107686 Such as granulocyte-macrophage colony stimulating factor; cytokines; kits; capsules |
05/08/2008 | US20080107668 Oligopeptides comprising epitopic sequences for use in induction of killer lymphocyte response in treatment of cell proliferative disorders |
05/08/2008 | US20080107667 Fusion peptide for use in targeting cells for lympocytic destruction; immunotherapy |
05/08/2008 | US20080107652 Using transgenic, probiotic microorgansims as therapeutic vechicles for prevention and treatment of infection in shrimp |
05/08/2008 | US20080107645 Antibody raised against a parasitic protozoan isolate; diagnostic assays for the detection of parasites in animals |
05/08/2008 | US20080107639 Secreted glycoprotein for use in prevention and treatment of obesity, diabetes, osteoarthritis, liver and hypertensive disorders |
05/08/2008 | US20080107637 Using inhalabe gas comprising ethyl nitrite as means of nitrosylating hemoglobin, delaying tumor growth and preventing destruuctive tissue damage associated with inflammation |
05/08/2008 | US20080107635 Selection and use of lactic acid bacteria for reducing inflammation in mammals |
05/08/2008 | US20080107634 Using mix comprising bifidobacterium and lactobacillus as tool in treatment of gastrointestinal and influenzal disorders |
05/08/2008 | US20080107633 Cultures of human CNS neural stem cells |
05/08/2008 | US20080107632 Mixture comprising blood clotting component, fibrinogen, aprontin and calcium for use in treatment of nervous system injury |
05/08/2008 | US20080107631 Liquid mixture comprising cryoprotectants and lyoprotectants for use in long term storage of viral particles |
05/08/2008 | US20080107629 Methods and compositions for gene therapy |
05/08/2008 | US20080107627 Use of sarp-1 for the treatment and/or prevention of scleroderma |
05/08/2008 | US20080107602 Neospora caninum isolate |
05/08/2008 | CA2668330A1 Mixed cell populations for tissue repair and separation technique for cell processing |
05/08/2008 | CA2667970A1 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type ii receptor (amhr-ii) |
05/08/2008 | CA2667959A1 Lithium stimulation of cord blood stem cell proliferation and growth factor production |
05/08/2008 | CA2667903A1 Composition for the treatment of skin conditions |
05/08/2008 | CA2636788A1 Pharmaceuticals that promote functional regeneration of damaged tissues |
05/07/2008 | EP1918380A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
05/07/2008 | EP1918373A1 Anti-obesity agent and anti-obesity food |
05/07/2008 | EP1918366A1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
05/07/2008 | EP1917974A1 Equine system for non-surgical artifical insemination |
05/07/2008 | EP1917969A1 Compositions for preventing depletion of the intestinal flora and organ damage following antibiotic treatment |
05/07/2008 | EP1917968A1 Methods and composition for complementing treatments to eradicate neoplastic cells |
05/07/2008 | EP1917967A1 Anti-aids drug |
05/07/2008 | EP1917960A1 Improved biological effects of rosmarinic acid |
05/07/2008 | EP1917869A1 Probiotic/non-probiotic combinations |
05/07/2008 | EP1917351A2 Attenuated reovirus |
05/07/2008 | EP1917350A2 A biological bypass bridge with sodium channels, calcium channels and/or potassium channels to compensate for conduction block in the heart |
05/07/2008 | EP1916911A2 Use of a symbiotic for the treatment of atopic dermatitis |
05/07/2008 | EP1729785B1 Eye drops consisting of filtered clayey water for treating glaucoma |
05/07/2008 | EP1691727A4 Particulate cartilage system |
05/07/2008 | EP1519755B1 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
05/07/2008 | EP1395269B1 Lipoteichoic acid from lactic acid bacteria for use as medicament and in the treatment of bacterial diseases |